These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


396 related items for PubMed ID: 10528184

  • 21. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
    Cheuk AT, Mufti GJ, Guinn BA.
    Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
    [Abstract] [Full Text] [Related]

  • 22. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP, Sauter BV, Huang TG, Meseck M, Woo SL, Chen SH.
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [Abstract] [Full Text] [Related]

  • 23. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    Battegay M, Moskophidis D, Waldner H, Bründler MA, Fung-Leung WP, Mak TW, Hengartner H, Zinkernagel RM.
    J Immunol; 1993 Nov 15; 151(10):5408-15. PubMed ID: 7693811
    [Abstract] [Full Text] [Related]

  • 24. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D, Speiser DE, Aebischer T, Hengartner H, Zinkernagel RM.
    J Immunol; 1993 Jun 01; 150(11):5051-8. PubMed ID: 7684417
    [Abstract] [Full Text] [Related]

  • 25. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
    Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, Kwon BS.
    Immunology; 2007 Jul 01; 121(3):349-58. PubMed ID: 17376197
    [Abstract] [Full Text] [Related]

  • 26. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC, Noel PJ, Podack ER, Reiner SL, Thompson CB.
    J Immunol; 1998 Mar 01; 160(5):2180-7. PubMed ID: 9498756
    [Abstract] [Full Text] [Related]

  • 27. Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.
    Hurtado JC, Kim SH, Pollok KE, Lee ZH, Kwon BS.
    J Immunol; 1995 Oct 01; 155(7):3360-7. PubMed ID: 7561030
    [Abstract] [Full Text] [Related]

  • 28. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT, Whitmire JK, Murali-Krishna K, Ahmed R, Altman JD, Mittler RS, Sette A, Pearson TC, Larsen CP.
    J Immunol; 2000 Mar 01; 164(5):2320-5. PubMed ID: 10679066
    [Abstract] [Full Text] [Related]

  • 29. 4-1BB (CD137) signals depend upon CD28 signals in alloimmune responses.
    Lee EA, Kim JE, Seo JH, Kwon BS, Nam SH, Kwon B, Cho HR.
    Exp Mol Med; 2006 Dec 31; 38(6):606-15. PubMed ID: 17202836
    [Abstract] [Full Text] [Related]

  • 30. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
    Molina TJ, Bachmann MF, Kündig TM, Zinkernagel RM, Mak TW.
    J Immunol; 1993 Jul 15; 151(2):699-706. PubMed ID: 8393038
    [Abstract] [Full Text] [Related]

  • 31. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
    Evans CF, Rall GF, Killeen N, Littman D, Oldstone MB.
    J Immunol; 1993 Dec 01; 151(11):6259-64. PubMed ID: 7902375
    [Abstract] [Full Text] [Related]

  • 32. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.
    Bot A, Holz A, Christen U, Wolfe T, Temann A, Flavell R, von Herrath M.
    Virology; 2000 Mar 30; 269(1):66-77. PubMed ID: 10725199
    [Abstract] [Full Text] [Related]

  • 33. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K, Lee SY, Cannons JL, Yeh WC, Santana A, Goldstein MD, Bangia N, DeBenedette MA, Mak TW, Choi Y, Watts TH.
    J Exp Med; 1998 Jun 01; 187(11):1849-62. PubMed ID: 9607925
    [Abstract] [Full Text] [Related]

  • 34. Role of 4-1BB in immune responses.
    Vinay DS, Kwon BS.
    Semin Immunol; 1998 Dec 01; 10(6):481-9. PubMed ID: 9826581
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD, Saha B, Hodes RJ, Abe R.
    J Immunol; 1996 Mar 15; 156(6):2112-8. PubMed ID: 8690899
    [Abstract] [Full Text] [Related]

  • 37. Alloreactive T cells that do not require TCR and CD8 coengagement are present in naive mice and contribute to graft rejection.
    Smith PA, Potter TA.
    J Immunol; 1998 Jun 01; 160(11):5382-9. PubMed ID: 9605138
    [Abstract] [Full Text] [Related]

  • 38. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W, Bertram EM, Sharpe AH, Watts TH.
    J Immunol; 2004 Nov 15; 173(10):5944-51. PubMed ID: 15528328
    [Abstract] [Full Text] [Related]

  • 39. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    Leist TP, Kohler M, Eppler M, Zinkernagel RM.
    J Immunol; 1989 Jul 15; 143(2):628-32. PubMed ID: 2544648
    [Abstract] [Full Text] [Related]

  • 40. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
    Hurtado JC, Kim YJ, Kwon BS.
    J Immunol; 1997 Mar 15; 158(6):2600-9. PubMed ID: 9058792
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.